Rossignol, J <br/><br/>
Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.  [electronic resource] 

 -  Leukemia  Mar 2011 
 - 473-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2010.278  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia, Hemolytic, Autoimmune--drug therapy<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--complications<br/>Male<br/>Middle Aged<br/>Purpura, Thrombocytopenic, Idiopathic--drug therapy<br/>Recurrence<br/>Red-Cell Aplasia, Pure--drug therapy<br/>Retrospective Studies<br/>Rituximab<br/>Thrombocytopenia--drug therapy